QSAR, Docking, and CoMFA Studies of GSK3 Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|24|2666-2675

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.24, 2010-08, pp. : 2666-2675

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Topomer CoMFA 3D-QSAR and Docking Studies of Pyrimidine Inhibitors of Pneumocystis Carinii Dihydrofolate Reductase

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 10, 2016-12 ,pp. : 1055-1062

Bentham Science Publishers

Access to resources Recommend Favorite

3D QSAR Pharmacophore, CoMFA and CoMSIA Based Design and Docking Studies on Phenyl Alkyl Ketones as Inhibitors of Phosphodiesterase 4

By  

Medicinal Chemistry, Vol. 8, Iss. 5, 2012-09 ,pp. : 894-912

Bentham Science Publishers

Access to resources Recommend Favorite

QSAR Studies on HSV-1 Inhibitors by CoMFA, CoMSIA and HQSAR Approaches

By  

Letters in Drug Design & Discovery, Vol. 7, Iss. 5, 2010-06 ,pp. : 332-340

Bentham Science Publishers

Access to resources Recommend Favorite

3D-QSAR Analysis on ATR Protein Kinase Inhibitors Using CoMFA and CoMSIA

By  

Current Computer - Aided Drug Design, Vol. 10, Iss. 4, 2014-12 ,pp. : 327-334

Bentham Science Publishers

Access to resources Recommend Favorite

3D-QSAR CoMFA and CoMSIA Study on Benzodipyrazoles as Cyclin Dependent Kinase 2 Inhibitors

By  

Medicinal Chemistry, Vol. 4, Iss. 4, 2008-07 ,pp. : 313-321

Bentham Science Publishers

Access to resources Recommend Favorite